SEC Form 4 · accession 0001583742-15-000001
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nasrat A Hakim
Officer — President & CEO · Director · 10% Owner
Period of report
Jun 2, 2015
Accepted (ET)
Jun 4, 2015 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 2, 2015 | C | 2,741,801 | $0.0625 | A | 5,311,819 | I | by Mikah Pharma LLC |
| Common Stock | holding | — | — | — | 13,760,695 | D | ||
| Common Stock | holding | — | — | — | 2,700,000 | I | by IRA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.0625 | Jun 2, 2015 | C | 759,695 | D | Oct 30, 2009 | Oct 30, 2016 | Common Stock | 759,695 | 0 | I |
| Warrants | $0.0625 | Jun 2, 2015 | C | 1,982,106 | D | Mar 31, 2011 | Mar 31, 2018 | Common Stock | 1,982,106 | 0 | I |